Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis

Figure 5

Effect of aprepitant or fasudil treatment on cardiac viral levels in viral-myocarditis. Relative cardiac EMCV RNA levels in EMCV-infected mice, with and without aprepitant or fasudil treatment. Results are expressed as the mean ± SEM (relative EMCV RNA levels of, , infected, with versus without aprepitant pretreatment, †, infected, with versus without aprepitant posttreatment, (, Student’s unpaired -test) (-4)).